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Sylvie Remya,d, Pascale Berckmansa, Adrian Covacic and Hilda WittersaABSTRACT: Zebrafish phenotypic assays have shown promise to assess human hepatotoxicity, though scoring of liver morphol-
ogy remains subjective and difficult to standardize. Liver toxicity in zebrafish larvae at 5days was assessed using gene expression
as the biomarker approach, complementary to phenotypic analysis and analytical data on compound uptake. This approach
aimed to contribute to improved hepatotoxicity prediction, with the goal of identifying biomarker(s) as a step towards the devel-
opment of transgenic models for prioritization. Morphological effects of hepatotoxic compounds (acetaminophen, amiodarone,
coumarin, methapyrilene and myclobutanil) and saccharin as the negative control were assessed after exposure in zebrafish
larvae. The hepatotoxic compounds induced the expected zebrafish liver degeneration or changes in size, whereas saccharin
did not have any phenotypic adverse effect. Analytical methods based on liquid chromatography–mass spectrometry were
optimized to measure stability of selected compounds in exposure medium and internal concentration in larvae. All compounds
were stable, except amiodarone for which precipitation was observed. There was a wide variation between the levels of com-
pound in the zebrafish larvae with a higher uptake of amiodarone, methapyrilene and myclobutanil. Detection of hepatocyte
markers (CP, CYP3A65, GC and TF) was accomplished by in situ hybridization of larvae to coumarin and myclobutanil and
confirmed by real-time reverse transcription–quantitative polymerase chain reaction. Experiments showed decreased expression
of all markers. Next, other liver-specific biomarkers (i.e. FABP10a and NR1H4) and apoptosis (i.e. CASP-3A and TP53) or cyto-
chrome P450-related (CYP2K19) and oxidoreductase activity-related (ZGC163022) genes, were screened. Links between basic
mechanisms of liver injury and results of biomarker responses are described. Copyright © 2016 John Wiley & Sons, Ltd.
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The liver is recognized as a critical target organ for xenobiotic
chemicals and drugs. Owing to its functional position between
the gastrointestinal tract and the systemic circulation, high con-
centrations of xenobiotics may end up in the liver after intestinal
absorption. Seven basic mechanisms for xenobiotic-induced liver
injury are known, i.e.: (1) disruption of calcium homeostasis and
cell membrane injury; (2) canalicular and cholestatic injury; (3)
metabolic bioactivation by cytochrome P450 enzymes; (4) mito-
chondrial injury, leading to interruption of lipid oxidation and
steatosis; (5) stimulation of autoimmunity; (6) stimulation of apo-
ptosis; and (7) (in)-direct activation of neutrophils and Kupffer cells.
Many of these mechanisms can be triggered at the same time in
an affected liver ( Jaeschke et al., 2002; Lee, 2003).
Hepatotoxicity evaluation is of high importance, but no single
in vitro/in vivo assay or battery of screens currently being per-
formed is able to predict reliably the biological effects of poten-
tially toxic compounds (Hill et al., 2012; Mennecozzi et al., 2012;
O’Brien et al., 2006; Xu et al., 2008). In vivo assessment of liver tox-
icity frequently involves histopathology requiring a large number
of rodents (Ekor et al., 2013). Rodent experiments are very labori-
ous, costly and time-consuming, with often poorly consistent re-
sults, while the EU-animal directive 2010/63/EU recommends the
reduction of scientific experiments on animals. Several alternative
in vitro methods to evaluate liver injury have been developed,J. Appl. Toxicol. 2016 Copyright © 2016 Johnincluding rat liver slices (Boess et al., 2003; Elferink et al., 2008),
rat or human primary hepatocytes (Boess et al., 2003; Kienhuis
et al., 2009), and hepatic cell lines, e.g., HepG2 and HepaRG
(Guillouzo et al., 2007; Lecluyse et al., 2012), each having their lim-
itations related to simplification of a cellular system compared to
the in vivo situation. Therefore, non-mammalian whole-organism
approaches are currently explored for their suitability to screen
for prediction of human toxicity and anticipate from the fore-
mentioned limitations.
Zebrafish embryos/larvae are often considered as alternative
systems, as these developmental stages are likely to experience
less or no pain, suffering, distress or lasting harm; therefore,Wiley & Sons, Ltd.
S. Verstraelen et al.developing zebrafish larvae are regarded as protected animals
only from 120h postfertilization (hpf ) onwards (EU, 2012). Further-
more, fish embryos provide the complexity and interaction of an
intact organism, enabling the evaluation of compound-induced
effects on multiple target organs. The transparent nature of the
embryo/larva, ability to screen the whole organism in a microwell
plate format with small amounts of compounds, potential to utilize
medium to high-throughput screening platforms (Pardo-Martin
et al., 2010), high degree of genetic conservation (Howe et al.,
2013) and their similar morphological andmolecular basis of tissue
and organ development (e.g., growth factor and gene expression
during liver budding, processing of lipids, vitamins, proteins and
carbohydrates in the tri-lobed liver) shared with other vertebrates,
including humans, makes zebrafish an excellent model organism
for studying complex biological processes (Chu & Sadler, 2009;
Howe et al., 2013; Vliegenthart et al., 2014).
Zebrafish larvae have been used as a convenient model for
assessing hepatotoxicity (Driessen et al., 2013; He et al., 2013; Hill
et al., 2012), as they complete primary liver morphogenesis by 48
hpf and the liver is fully formed and functioning by 72 hpf
(Alderton et al., 2010; Isogai et al., 2001; Pack et al., 1996). In addi-
tion, zebrafish homologs of mammalian lipid metabolizing
enzymes are present in the zebrafish liver (Chng et al., 2012;
Goldstone et al., 2010; Wiegand et al., 2000). A transcriptomic-
based comparison of hepatotoxicity for three compounds (amio-
darone [AMI], acetaminophen [ACE] and cyclosporine A) between
the zebrafish embryo and traditional models (i.e. in vivomouse and
rat liver, in vitro mouse and rat hepatocytes, and primary human
hepatocytes) showed concordance at the pathway level (metabo-
lism) and confirmed its potential as a model to screen for the
hepatotoxic potential of compounds (Driessen et al., 2015).
The objective of our research project was to explore zebrafish
larvae as an alternative whole-organism approach to evaluate
the potential of compounds to induce hepatotoxicity and compare
with rodent studies and human health effects. Liver toxicity in
zebrafish larvae was assessed using gene expression (in situ hy-
bridization [ISH] and real-time reverse transcription–quantitative
polymerase chain reaction [RT-qPCR]) as the biomarker approach,
complementary to phenotypic analysis. A measure of compound
uptake via bioanalysis (i.e. a liquid chromatography [LC]/mass
spectrometry [MS] based approach) is rather unique and impor-
tant to interpret appropriately the relevance of any observed
toxicity outcome of the bioassay in relation to stability and bio-
availability of the test compound, and allows explanation of the
eventual false negative results. For that reason, analytical methods
were optimized to analyze the stability, as well as the medium and
internal concentration of selected hepatotoxic compounds. This
multifaceted approach is of added value to existing studies with
zebrafish larvae, which mainly study either gene expression
(Driessen et al., 2014, 2015), bioactivation of test compounds and
metabolite profiling (Chng et al., 2012), morphology and histopa-
thology (He et al., 2013; Hill et al., 2012), or a combination of these
approaches (Driessen et al., 2013; Mesens et al., 2015), but they all
lack the extensive analytical study on the fate of the test compounds.
In this study, morphometric evaluation of the zebrafish liver,
complemented with gene expression studies and analytical results
are presented for one non-hepatotoxic compound, saccharin
(SAC) and five hepatotoxic compounds, i.e. ACE, AMI, coumarin
(COU), methapyrilene (MET) and myclobutanil (MYC). The expected
positive and negative compounds were selected from mammalian
studies, representing different mechanisms (cfr. Table 1 and discus-
sion) and were evaluated in the zebrafish model with the purposeCopyright © 2016 Johnwileyonlinelibrary.com/journal/jatof assessing the predictive value of zebrafish in relation to the basic
mechanisms for xenobiotic-induced liver injury. In summary, the
novelty at the level of experimental approach is combining liver
morphology, biomarker assessment (ISH and RT-qPCR) and fate of
compound. The selection of appropriate biomarker(s) offers new per-
spectives for the development of a transgenic model as a screening
tool to prioritize unknown substances for hepatotoxicity.
Materials and methods
Zebrafish
Adult, wild-type zebrafish (Danio rerio) were obtained from a
commercial dealer, and were kept in the laboratory as breeding
fish for this study and reared under standard conditions (tem-
perature range 25–27°C) at a 14: 10 light/dark cycle. The fish
were acclimated to laboratory conditions, and kept in quaran-
tine for at least 2 weeks before use in experiments. Next, healthy
male and female fish were used to generate zebrafish embryos
by group breeding in breeding tanks. Eggs were rinsed in
0.0002% methylene blue (CAS no. 122965–43-9; Sigma-Aldrich,
Diegem, Belgium), diluted in fish water (reverse osmosis
water supplemented with CaCl2.2H2O [0.294g l
–1], MgSO4.7H2O
[0.123g l–1], KCl [0.006 g l–1], and NaHCO3 [0.065 g l
–1];
pH 7.0–8.5; conductivity 600–700 μS cm–1; hardness 10–300mg l–1
CaCO3; oxygen level > 80% [OECD TG 203, 1992]) and placed
into large Petri dishes filled with fish water. At 6 hpf, unfertilized
eggs were removed and the embryos were transferred to six-
well plates (five embryos per well per 4ml fish water) and
placed in an incubator at a 14: 10 light/dark cycle at 28.5± 0.5°C
until 72 hpf. The procedures described in this studywere approved
by the local ethics committee.Chemical treatment
A hepatotoxic compound database containing 89 compounds was
created based on mammalian data from peer-review articles (e.g.,
PubMed) and other databases (e.g., TOXNET-HSDB). For the selec-
tion of target hepatotoxic compounds, toxicological and analytical
selection criteria were used, such as “different chemical classes, dif-
ferent mode-of-action, different physico-chemical characteristics,
availability of compound in pure form.” Five hepatotoxic com-
pounds (i.e. ACE, AMI, COU,MET andMYC) and one non-hepatotoxic
compound (SAC) were finally selected for assessing hepatotoxicity
in larval zebrafish (see Table 1). All the compounds were purchased
from Sigma-Aldrich. Stock solutions were prepared in either 100%
dimethyl sulfoxide (DMSO, CAS no. 67–68-5; Lab-Scan, Gliwice,
Poland) (AMI, COU, MET and MYC) or fish water (ACE and SAC)
and dilutions weremade in fishwater with 0.1%DMSOor fishwater.
An optimal experimental set-up was derived from our own pre-
liminary experiments. At 72 hpf, the six-well plates with larval
zebrafish were checked for normal development and the minority
of abnormal larvae (e.g., non-hatched, edema<10%) was replaced
before the start exposure to test compounds. For all experiments,
2× six-well plates with five zebrafish larvae each were statically
exposed to the negative control (fresh fish water), if a solvent
was used, to the solvent control (0.1% DMSO in fish water), or to
three sublethal concentrations of test compounds for a treatment
period of 48 h (from 72 to 120 hpf ) in an incubator on a 14: 10
light/dark cycle at 28.5 ± 0.5°C. For real-time RT-qPCR, three techni-
cal repeats, each with 2× six-well plates containing five larvae,








































































































































































































































































































































































































































































































































































































































Evaluation of zebrafish as alternative model to predict hepatotoxicity
J. Appl. Toxicol. 2016 Copyright © 2016 John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jat
S. Verstraelen et al.sublethal concentrations of the test compounds ranged fromno or
small effect on the liver to clear the toxic effect on the liver, while
causing no larvae mortality, as these were derived in range-finding
experiments using the optimal experimental set-up (Table 1).Phenotypic evaluation of hepatotoxicity
After 48 h treatment, zebrafish larvae at 120 hpf were subject to
visual observation of liver morphology under a stereomicro-
scope (Olympus IX2-UCB, Berchem, Belgium) at magnification
100×. Larvae were first immobilized in 2% methylcellulose
(CAS no. 9004–67-5; Sigma-Aldrich). When viewed
dorsolaterally, the liver is situated posterior to the pericardium
and predominantly anterior to the gut. The liver is globular in
structure, has a clearly recognizable periphery against the
neighboring tissues and is perfused with circulating blood cells.
Normal zebrafish liver is clear, whereas after treatment with
hepatotoxic compounds, it became darker with gray coloration
and the texture of liver tissue became amorphous, indicating
degeneration and/or necrosis. Two specific phenotypic end-
points, respectively changes in liver size and liver degeneration,
were visually assessed for hepatotoxicity. Other non-liver specific
characteristics were noted, e.g., edema, non-inflated swim blad-
der, protruding mouth (not shown). At least two to five indepen-
dent biological experiments using different batches of zebrafish
larvae and freshly made test solutions were performed. For each
experiment and each test concentration, the number of fish
showing effect for each of the two endpoints was scored, as well
as those showing a normal liver, and expressed in Table 3 as the
percentage effect. In this way, percentage values in Table 3 show
for each condition the range of effects across experiments, being
more informative than the calculation of a mean value for the
percentage effect, masking the variability between experiments.Biomarker evaluation of hepatotoxicity
Potential gene markers for liver injury were studied by whole-
mount ISH and real-time RT-qPCR to complement the phenotypic
hepatotoxicity assessment.
Biomarker selection. Six liver-specific biomarkers with a clear
orthologous gene in zebrafish and four non-liver specific bio-
markers were selected from mammalian and zebrafish studies
(occurrence in liver mammals, evidence for changes due to hepa-
totoxicity in general) and are shown in Table 2.
Whole-mount in situ hybridization. Whole-mount ISH for the
markers CP, CYP3A65, GC and TF was performed following an
adapted protocol (Mavropoulos et al., 2005). At 24 hpf, pigmenta-
tion was blocked by adding 0.0003% phenylthiocarbamide (CAS
no. 103–85-5; Sigma-Aldrich) to improve visual observation. ISH
experiments were performed using fixed larvae at 120 hpf after
48h exposure to COU (250 and 500μM), MYC (12.5 and 25μM) or
the solvent control (0.1% DMSO in fish water). Details on the
protocol can be found in Supplementary Information.
Real-time reverse transcription–quantitative polymerase chain reac-
tion. Biomarkers (CP, CYP3A65, GC and TF) with a clear difference
in expression in treated larvae compared to control larvae in the
ISH experiments were quantitatively confirmed using real-time RT-
qPCR. In addition, other liver-specific biomarkers (i.e. FABP10a and
NR1H4), apoptosis as well as additional metabolism/oxidoreductase-
related markers i.e. CASP3A, TP53, CYP2K19 and ZGC163022 wereCopyright © 2016 Johnwileyonlinelibrary.com/journal/jatselected to verify whether these genes were influenced by expo-
sure to hepatotoxicants. After 48h exposure, the two wells with
five larvae each for each condition were pooled in a single tube
(n=10 larvae), snap-frozen in liquid nitrogen and homogenized
in TRIzol (TRI reagent; Ambion, ThermoFisher Scientific, Gent,
Belgium) using the SilentCrusher S (Heidolph Instruments,
Schwabach, Germany). Three technical repeats were performed
for each exposure condition within the same experiment, and for
each compound at least three independent biological experiments
were set up. Details on the protocol and statistical analysis can be
found in Supplementary Information.Chemical analysis
For chemical analysis, two replicate wells of five zebrafish larvae
were statically exposed to the negative control, eventually to the
solvent control, and to three sublethal concentrations of test com-
pounds (Table 1). The identification and quantitation of the
selected compounds were executed using a LC (1200 series;
Agilent Technologies, Diegem, Belgium), equipped with a binary
pump and coupled to a triple quadrupole MS (Agilent Technolo-
gies 6410) equipped with an electrospray ionization source. The
LC parameters for each chemical are given in Supplementary Infor-
mation Table S2. For SAC, an Agilent Zorbax SB-C18 column
(2.1×50mm, 3.5μm) was used, while all other compounds were
analyzed using a Phenomenex Kinetex C18 column (2.1×100mm,
2.6μm). The mobile phase was composed from eluent Ag (MilliQ
water with 0.1% formic acid; Merck, Overijse, Belgium) and elu-
ent B (methanol or acetonitrile, Merck with 0.1% formic acid).
Supplementary Information Table S3 gives an overview of the
MS parameters for each compound and its internal standard, the
latter being chosen from the same chemical class as the analyte.
The stability of each chemical was determined during the expo-
sure period of 48 h at 28.5± 0.5°C in a plastic well plate at 14: 10
light/dark cycle, storage at 4°C in a glass vial, and transport at room
temperature in a glass vial. The highest exposure concentration
was used to determine the stability at 28.5°C in a plastic well plate,
except for MET which was twice as high (Supplementary Informa-
tion Table S4, 21.3μM).
Test compound concentration measurement in medium. At the
start of exposure (72 hpf; n=1 technical repeat/condition) and at
the end of exposure after 48 h treatment (120 hpf; n=2 technical
repeat/condition), the exposure medium was collected and the
concentration of test compound was measured. The media of
blank wells were also collected to demonstrate compound avail-
ability in the absence of larvae (i.e. how much compound may
have degraded or adsorbed to the plastic during the assay). The
average of measured concentrations of two independent experi-
ments and standard deviation were calculated. The medium
samples were diluted in fish water and the calibration for each
compound was made in fish water or in 0.1% DMSO in fish water.
Supplementary Information Table S4 gives for each compound the
limit of detection, limit of quantification, range of linearity range,
accuracy at low and high reference level and precision at low
and high reference level in fish water.
Determination of compound concentration in zebrafish larvae. Af-
ter exposure (120 hpf ), two replicates of five larvae each (n=2/
condition) were washed three times in 1% DMSO, if 0.1% DMSO
as solvent was used for exposure, or fish water to eliminate
compound adsorbing to the outside of the larvae and collected
to measure actual systemic compound uptake. CompoundJ. Appl. Toxicol. 2016Wiley & Sons, Ltd.
Table 2. Overview biomarkers. The relation of the liver markers to the basic mechanisms of xenobiotic-induced liver injury is men-
tioned between brackets in the column “relevance in mammals:” (1) disruption of calcium homeostasis and cell membrane injury;
(2) canalicular and cholestatic injury; (3) metabolic bioactivation by cytochrome P450 enzymes; (4) mitochondrial injury; (5) stimulation
of autoimmunity; (6) stimulation of apoptosis; (7) (in)direct activation of neutrophils and Kupffer cells
Gene name Gene symbol Relevance in mammals Occurrence in zebrafish
Albumin-like GC Liver marker (1)
(Lee et al., 1987)
(Noel et al., 2010)
Ceruloplasmin CP Liver marker (2, 7)
(Koruk et al., 2003)








Liver and gut marker
(Tseng et al., 2005)
Liver fatty acid
binding protein
FABP10a Liver marker (*),
reflective of liver
health and homeostasis
(Chu and Sadler, 2009;
Monbaliu et al., 2005)




NR1H4 Liver marker (2,3,4)
(Heni et al., 2013)
Personal communication
Hill A. (2010)
Transferrin TF Liver marker (*)
(Amacher, 2002)
(Mudumana et al., 2004;
Noel et al., 2010)
Caspase 3a CASP3A Non-liver specific
apoptosis marker
(Porter and Jänicke, 1999)




CYP2K19 Shares synteny with human
CYP2W1, a tumor-specific
CYP that oxidizes indole
and chlorzoxazone, but









(Amaral et al., 2010)
Lam et al., 2013
Ferric chelate
reductase 1
ZGC163022 – Oxidoreductase metabolism
(Driessen et al., 2013)
* Drug-induced liver injury marker, not specified.
Evaluation of zebrafish as alternative model to predict hepatotoxicityconcentration in larvae was calculated according to Berghmans
et al. (2008 where the volume of a larva was equated to 1.67μl.
The concentration in larvae was calculated (μM) and relative up-
take of compound into larvae was presented as percentage of
the start concentration in the mediummeasured at the beginning
of the experiment, except for AMI where nominal concentration
was used. The average compound concentration in larvae of
two independent experiments was calculated with the corre-
sponding standard deviation. For the analysis of exposed larvae,
we have used matrix-matched calibration using non-exposed lar-
vae to account for the matrix effect during the analysis. The cali-
bration was first made in 100% methanol, the standards were
then evaporated and reconstituted in 100μl of blank larvae in
methanol/water (1: 1). A volume of methanol/water 1: 1 was
added to the larvae samples, the larvae were ultrasonicated until
they were dissolved (typically 10min), then vortexed for 1min.
The entire sample was centrifuged for 1min at 10 000 rpm and
the supernatant was injected into the LC–MS/MS.
The quality control reference samples were prepared by spiking
the analytes to non-exposed larvae. The solvent ratio in the non-J. Appl. Toxicol. 2016 Copyright © 2016 Johnexposed larvae was methanol/water (1: 1). More details are given
in Supplementary Information Table S4.Results
Phenotypic evaluation of hepatotoxicity
Zebrafish treatedwith the negative (fish water) and solvent control
solution (0.1% DMSO in fish water) exhibited clear liver tissue
(Fig. 1a). After treatment with certain tested concentrations of a
hepatotoxic compound, e.g., MET, zebrafish liver lost transparency
and became dark (Fig. 1c,d) or changes in liver size were observed
(Fig. 1d), while the lowest concentration of MET (2.5μM) did not
show phenotypic effects on the liver (Fig. 1b) compared to the
control. The non-hepatotoxic compound SAC did not exhibit any
of these phenotypic effects on larval zebrafish liver for all tested
concentrations. The effect percentages of evaluated phenotypic
endpoints after 48 h exposure of zebrafish larvae to hepatotoxic
compounds and a non-hepatotoxic compound SAC, comparedWiley & Sons, Ltd. wileyonlinelibrary.com/journal/jat
Figure 1. Phenotypic identification of hepatotoxicity at 120 hpf treated for
48 h, the liver region is indicated by an arrow (magnification × 100). Control
larva (a) and larva treated with 2.5μM methapyrilene (b) exhibit a clear,
healthy liver. Larvae treated with higher concentrations of the
hepatotoxicant methapyrilene exhibit tissue degeneration (c,d) and
changes in liver size (d), with more toxic responses as was observed by
pericard edema, protruding mouth and an uninflated swim bladder at
the highest concentration (d).
S. Verstraelen et al.to the corresponding negative/solvent control are shown in
Table 3. For each of the experiments, percentage effect values
are presented that point to rather a high variability at the highest
concentrations, e.g., for liver degeneration, 1000μM COU resulted
in a percentage effect range of 11–100% across five experiments.Biomarker evaluation of hepatotoxicity
Whole-mount in situ hybridization. In Fig. 2, ISH results are shown
for the marker TF as example. An overview of all ISH results isCopyright © 2016 Johnwileyonlinelibrary.com/journal/jatpresented in Supplementary Information Table S5. Exposure to
both concentrations, COU affects all hepatocyte markers and a
strongly decreased expression in the liver was observed compared
to the solvent-treated larvae. MYC causes a slightly reduced ex-
pression of hepatocyte markers for both concentrations compared
to the solvent control. Only exposure to 12.5μM MYC showed no
change in expression for the marker GC compared to the solvent
control.
Real-time reverse transcription–quantitative polymerase chain reac-
tion. Results are shown in Fig. 3(a–c). Below, we describe the ex-
posure conditions that induced a significant change in expression
(P< 0.05) relative to solvent control by mixed-effect model analy-
ses followed by Tukey’s post-hoc testing in R and exceeding the
threshold of effect size (abs(log2(FC)) above log2(1.5)). The expo-
sure conditions not inducing significant changes and/or for which
the threshold of effect size was not met, are not described in detail
in the text but can be derived from the figures. Significance of
pairwise comparisons between different treatments (concentration)
is given by Supplementary Information Table S7 and enables infor-
mation to be derived on concentration–response relationships.
Hepatotoxicity-associated gene expression in 120 hpf zebrafish larvae
exposed for 48h (Fig. 3a). The ISH results (see “Whole-mount in
situ hybridization”) were confirmed for COU. Exposure to COU re-
duced the expression of CP, CYP3A65, GC, FABP10a and TF. Next,
the hepatotoxicity-associated markers were also screened for
ACE, AMI, MET and SAC. Strong effects on gene expressionwere in-
duced by ACE and AMI. ACE induced downregulation of TF, CP,
FABP10a and GC. A similar response could be observed after expo-
sure to AMI. The highest concentration of AMI also upregulated
the expression of CYP3A65. MET and MYC were the least potent
chemicals based on gene expression changes of the selected
markers. Overall, SAC showed no change in expression, except
for the highest concentration that induced little effect on CP and
GC. The marker NR1H4 is expressed in zebrafish, but no change
in expression above the threshold of effect was observed for this
marker for any compound.
Statistical evidence of concentration–response relationships
can be derived from Supplementary Information Table S7 in
which pairwise differences between chemical concentrations
were analyzed. The results support that there is indication for
concentration–response (systematic increase or decrease) for
the following liver-specific markers: CP after exposure to AMI;
CYP3A65 after exposure to AMI and COU; FABP10a after expo-
sure to ACE, AMI and COU; GC after exposure to ACE, AMI
and COU; TF after exposure to ACE and AMI.
Apoptosis and/or metabolism-related/oxidoreductase activity in ex-
posed 120 hpf zebrafish larvae. Two apoptosis-related markers
(CASP3A and TP53; Fig. 3b) and metabolism/oxidoreductase-
related markers (CYP2K19 and ZGC163022; Fig. 3c) were tested to
check if these genes are influenced by exposure to the test com-
pounds. In larvae, exposed to ACE and AMI, transcription of
CASP3A was stimulated for the two highest concentrations. The
same was true for themarker TP53 after ACE exposure. The marker
ZGC163022was increased in expression by ACE (5000μM) and COU
exposure (all concentrations). On the other hand, for AMI, down-
regulation of ZGC163022 was observed after exposure to 1μM.
CYP2K19was increased in expression for 5μM AMI. On the contrary,
for ACE and COU (all concentrations), CYP2K19was downregulated.
Potential genemarkers to predict human hepatotoxicity. The com-
pounds ACE, AMI and COU show a decreased expression of mostJ. Appl. Toxicol. 2016Wiley & Sons, Ltd.
Table 3. Effect percentages of evaluated phenotypic endpoints after 48h exposure of zebrafish larvae to hepatotoxic compounds
and a non-hepatotoxic compound SAC, compared to corresponding NC/SC. Effect percentages were calculated only for the living lar-






Effect percentages for phenotypic endpoints (%)
Clear, healthy liver Changes liver size Liver degeneration
ACE (n=2) 2000 80–100 0–0 0–20
4000 11–56 11–22 22–56
5000 10–11 0–33 56–80
AMI (n=3) 0.2 90–100–100 0–0–0 0–0–10
1 60–100–100 0–0–10 0–0–30
5 20–40–60 0–20–50 40–50–60
COU (n=4–5) 250 50–70–80–100–100 0–0–0–10–50 0–0–0–10–20
500 0–10–30–89 0–11–30–60 11–30–30–80
1000 0–0–0–22 0–0–40–56 11–20–70–100
MET (n=5) 2.5 100–100–100–100–100 0–0–0–0–0 0–0–0–0–0
5 90–100–100–100–100 0–0–0–0–10 0–0–0–0–0
10 0–20–60–60–70 10–10–25–40–70 0–20–30–70–75
MYC (n=3–5) 12.5 90–90–100–100–100 0–0–0–0–10 0–0–0–0–10
25 89–100–100 0–0–0 0–0–11
50 10–20–30–40 0–0–20–40 30–40–60–80
SAC (n=2) 3400 100–100 0–0 0–0
6800 100–100 0–0 0–0
13 700 100–100 0–0 0–0
NC (n=4) Fish water 100–100–100–100 0–0–0–0 0–0–0–0
SC (n=18) 0.1% DMSO in fish water 100 0 0
aACE, acetaminophen; AMI, amiodarone; COU, coumarin; DMSO, dimethyl sulfoxide; FC, fold change; MET, methapyrilene; MYC,
myclobutanil; n, number of independent biological experiments; NC, negative control; SAC, saccharin; SC, solvent control.
Figure 2. In situ hybridization images of 120 hpf zebrafish larvae after 48 h exposure to the SC (0.1% dimethyl sulfoxide in fish water), 250 and 500μM cou-
marin (a), and 12.5 and 25μM myclobutanil (b) for the marker transferrin. The liver region is indicated by an arrow. SC, solvent control.
Evaluation of zebrafish as alternative model to predict hepatotoxicityhepatotoxic markers. On the other hand, MET and MYC show a
minor response for differential gene expression of only a few
markers indicating that these compounds are less potent in the
zebrafish model compared to ACE, AMI and COU, despite pheno-
typic effects at the highest test concentration.Chemical analysis
Test compound concentration measurement in medium. An over-
view of the compound concentration measurements in the
medium as a function of the nominal concentration at the
beginning and end of exposure, and in blank wells at the
end is presented in Fig. 4(a–e). These results show a good agree-
ment between the measured concentration of the testJ. Appl. Toxicol. 2016 Copyright © 2016 Johncompounds in the medium compared to the nominal concentra-
tion and between the measured concentrations at the begin-
ning of an experiment versus the concentration at the end
for all compounds.
Determination of compound uptake by zebrafish larvae. The
whole body concentration of compound uptake in zebrafish lar-
vae as a function of the nominal concentration in the medium
is shown in Fig. 5(a–f ). For exposure to ACE, AMI, MET and MYC
an increase in compound uptake in the larvae is shown with in-
creasing concentration in the exposure medium. For AMI, MET
and MYC (highest nominal concentration), the uptake concentra-
tion in the larvae was higher than the nominal concentration, in-
dicating a bioconcentration of test compound in the larvae.
Larvae exposed to 250 and 500μM COU showed the same lowWiley & Sons, Ltd. wileyonlinelibrary.com/journal/jat
Figure 3. (a–c) Real-time reverse transcription–quantitative polymerase chain reaction results of (a) liver-specificmarkers (CP, CYP3A65, FABP10a,GC,NR1H4,
TF), (b) apoptosis-related markers (CASP3a and TP53) and (c) metabolism/oxidoreductase-related markers (CYP2K19 and ZGC163022) after 48 h exposure of
zebrafish larvae to three sublethal concentrations of hepatotoxic compounds (shown on x-axis) ACE, AMI, COU, MET andMYC and the non-hepatotoxic com-
pound SAC. The average log2 FC and 95% confidence interval (error bars) of three independent biological experiments are shown. The threshold FC of log2
(1.5) is shown by a dotted line. Treatments for which the effect crosses the threshold of effect and for which the effect is statistically significant compared to
the solvent control group (P< 0.05 Tukey’s test) are presented by “*”. ACE, acetaminophen; AMI, amiodarone; COU, coumarin; FC, fold change; MET,
methapyrilene; MYC, myclobutanil; SAC, saccharin.
S. Verstraelen et al.
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Evaluation of zebrafish as alternative model to predict hepatotoxicitylevel (~3μM) of compound uptake, which doubled when exposed
to the highest concentration (1000μM). Low whole body concen-
trations compared to medium were also seen for exposure to
SAC, but actual concentrations reached 80–120μM, which is of
same order of magnitude as for some hepatotoxic compounds
(ACE, MYC, MET).
On the second y-axis of Fig. 5(a–f ), the relative compound up-
take is shown, which is the percentage of themeasured concentra-
tion in the medium at start in function of the nominal
concentration. Results on relative uptake can be expressed as high
(> 100%), medium (5–100%) or low (< 5%) uptake relative to the
test solution concentration as proposed by Gustafson et al. (2011).
A low relative uptake compared to the nominal concentration was
observed for the compounds COU and SAC. ACE exposure resulted
in a medium uptake (from 5 to 12%) in zebrafish larvae. High rela-
tive compound uptake (range 100–1000%, or up to 10-fold
bioconcentration for MET) in zebrafish larvae was observed after
exposure to AMI (nominal concentration: 1 and 5μM), MET and
MYC (nominal concentration 50μM).Discussion
Phenotypic evaluation
In the current model, 72 hpf zebrafish was found to be an optimal
developmental stage with a fully functional liver (Isogai et al., 2001)
and 48h exposure was sufficient to see the compound effects un-
der the microscope (Hill et al., 2012). Visualizing zebrafish liver
requires manual manipulation and proper orientation of the ani-
mals in 2% methylcellulose. Here, phenotypic assessment of gross
morphological changes was used to screen for liver toxicity and to
define sublethal concentrations for gene expression experiments.
Despite some variation between the independent experiments
(cfr. Table 3), we found that all the assessed mammalian hepato-
toxic compounds induced the expected liver degeneration or
changes in liver size for certain tested concentrations, whereas
the non-hepatotoxic compound SAC did not have any phenotypic
adverse effect on zebrafish liver. This method to assess liver
toxicity in zebrafish larvae, supplemented with observations on
decreased yolk sac retention upon hepatotoxicity was also suc-
cessfully applied by others (He et al., 2013; Hill et al., 2012), though
scoring of liver morphology remains subjective and difficult to
standardize unless automated imaging systems are developed
(Pardo-Martin et al., 2010). Phenotypic evaluations in zebrafish
larvae were extended with histopathological studies of the liver
(Driessen et al., 2013, 2014) for nine hepatotoxicants, categorized
according to their known phenotypes in humans: cholestasis,
steatosis and necrosis. Distinct histopathological changes (lipid
vacuoles, chromatin condensation, eosinophilic vacuolization)
were observed in some zebrafish larvae depending on the treat-
ment. Frequency and type of effects did not allow to distinguish
nominal mammalian phenotypes and the incomplete maturation
of liver in the zebrafish larvae (Driessen et al., 2013, 2014). Two of
the nine compounds, ACE and AMI, were in commonwith our study
with, respectively, a lower concentration range (up to 660μM) and
higher range (up to 10μM) compared to our range-finding experi-
ments (up to 5000μM for ACE and 5μM for AMI). The concentrations
were differently defined in both studies. In the studies of Driessen
et al., the highest concentration had no observable generalmorpho-
logical or teratological effects and no mortality. In our study, the
highest concentrations were sublethal and specifically defined as
those having a clear toxic effect on the liver.J. Appl. Toxicol. 2016 Copyright © 2016 JohnBiomarker evaluation
Driessen et al. (2013 extended the fore-mentioned histopatholog-
ical evaluation with gene expression analysis in whole zebrafish
embryos (120 hpf ) compared to the liver of adult zebrafish for a
set of reference hepatotoxic compounds, including ACE and AMI.
Some hepatotoxicity-associated genes were only present in whole
zebrafish embryo, e.g., FABP10a. Mesens et al. (2015 showed prom-
ising predictivity for the hepatotoxic effects in zebrafish larvae by
studying the expression of FABP10a as an appropriate endpoint.
This marker was also studied in our experimental set-up. To study
hepatic gene expression, it was decided to use whole zebrafish lar-
vae RNA extracts as the most practical way in this study.
Hepatotoxicity-associated gene expression responses remain de-
tectable in the noise of other tissues and were not hampered by
the developmental stage of the whole zebrafish larvae.
The most common drug causing drug-induced liver injury is
ACE. When an accidental or deliberate overdose occurs, the reac-
tive metabolite N-acetyl-p-benzoquinone imine is produced by
CYP450 enzymes (Nelson, 1990). Excess of this reactive metabolite
causes oxidative stress in humans and mice by depleting glutathi-
one and results in mitochondrial damage and necrotic cell death
(McGill et al., 2012). Compounds that damagemitochondrial struc-
ture, enzymes or DNA synthesis can disrupt β-oxidation of lipids
and oxidative energy production within the hepatocytes. Prolonged
interruption of β-oxidation leads to micro/macrovesicular steatosis
(Cullen, 2005). In this zebrafish study, high concentrations (mM range)
of ACE were used to observe any phenotypic effects on the liver,
which is in analogy with other zebrafish reports (He et al., 2013).
CYP3A65 gene expression was not altered after ACE exposure,
which is possible as not all CYPs are regulated at the mRNA level
by their substrates. All other hepatotoxicity-associated genes, ex-
cept NR1H4, were decreased in expression after ACE exposure. In
patients with ACE overdose, total and free GC-globulin serum
levels were decreased as a sign of hepatotoxicity (Amacher
et al., 2005; Lee et al., 1987; Schiodt et al., 2001). As a cellular de-
fense response against oxidative stress induced by ACE (McGill
et al., 2012), genes involved in oxidoreductase metabolism were
increased in the expression as also observed in the zebrafish
model in this study for ZGC163022 (5mM ACE) and in the study
of Driessen et al. (2014 it was 660μM.
In this gene expression study of zebrafish, all hepatotoxic
markers, except NR1H4, were decreased in expression for at least
one tested concentration of AMI. The apoptotic marker CASP3A
and metabolism-related gene CYP2K19 were increased in expres-
sion. The other marker ZGC163022 was decreased in expression,
whereas in the study of Driessen et al. (2014 this marker was in-
creased after exposure to 10μM AMI, which is a twofold higher
concentration than in our study.
COU exhibits marked species differences in both metabolism
and hepatotoxicity. In zebrafish larvae, all liver-associated gene
markers, except NR1H4, were decreased in expression, as also ob-
served for the other known model hepatotoxic compounds ACE
and AMI. As also observed in rat studies (Lake et al., 2002; Uehara
et al., 2008), increased expression of ZGC163022 points to in-
creased oxido-reductase activity.
MET is a known hepatotoxin in rats. It was found that
enterohepatic recirculation of metabolites was important for its
hepatotoxicity (Ratra et al., 2000). MET was also indicated as a
severely hepatotoxic compound in humans (O’Brien et al.,
2006). In this experimental set-up, only TF was statisticallyWiley & Sons, Ltd. wileyonlinelibrary.com/journal/jat
Figure 4. (a–e) Test compound concentration measurement in medium. The average measured concentration (μM, y-axis) with standard deviation of two
independent experiments was plotted against the nominal concentration (μM, x-axis) for exposure to three sublethal concentrations of four hepatotoxicants.
Only one experiment was performed for SAC. For MET, concentration in blank wells was measured for only one experiment. ACE, acetaminophen; COU, cou-
marin; MET, methapyrilene; MYC, myclobutanil; SAC, saccharin.
Figure 5. (a–f ) Compound uptake by zebrafish larvae. The average and standard deviation of measured compound concentration in larvae (μM, left y-axis,
column) and the relative uptake of the compound in larvae as a percentage of the nominal concentration in the medium at the start (%, right y-axis, line) is
plotted against the nominal concentration in the medium for exposure to three sublethal concentrations of hepatotoxicants (μM, x-axis). Results of two in-
dependent experiments, except for SAC only one experiment was performed. ACE, acetaminophen; AMI, amiodarone; COU, coumarin; MET, methapyrilene;
MYC, myclobutanil; SAC, saccharin.
S. Verstraelen et al.significantly decreased in expression after 5μM MET exposure,
which is not really convincing for a good model for hepatotoxic
compounds.Copyright © 2016 Johnwileyonlinelibrary.com/journal/jatMYC induces hepatotoxicity in mouse and rat by CYP450 meta-
bolic bioactivation leading to perturbation of fatty acid, steroid
and xenobiotic metabolism pathways through an adrostaneJ. Appl. Toxicol. 2016Wiley & Sons, Ltd.
Evaluation of zebrafish as alternative model to predict hepatotoxicityreceptor and pregnane X receptor signaling pathways (Goetz and
Dix, 2009; Goetz et al., 2006). The hepatic gene markers and
metabolism/oxidoreductase or apoptosis-related genes were not
statistically significantly affected after MYC exposure in zebrafish.
Exposure to MET and MYC resulted in no statistically significant
response of any hepatotoxic marker, except for 5μM MET for the
marker TF, and none of the apoptosis- or stress-related markers
compared to the strong gene responses induced by ACE, AMI
and COU exposure.
A goodmarker to predict hepatotoxicity should give a response
after exposing zebrafish larvae to hepatotoxic compounds and not
non-hepatotoxic compounds. Our gene expression studies dem-
onstrated that four of six tested hepatotoxic markers, more specif-
ically CP, FABP10a, GC and TF are promising markers as a step
towards the development of transgenic models for screening
(Fig. 3a), which is the final goal of this project. These four genes
showed a decreased expression after ACE, AMI and COU exposure,
which was often concentration dependent. This was clearly differ-
ent from the negative compound SAC, which only induced a small
effect at the highest concentration on CP and GC. At first, a TF
transgenic zebrafish will be developed and with successful con-
struction, its complementarity will be checked to the existing
FAPB10a transgenic line (Mesens et al., 2015). TF is highly
expressed in the adult mammalian liver and is secreted by hepato-
cytes into the serumwhere it functions as an iron transport protein
and growth factor for a variety of cells (de Jong et al., 1990; Zakin,
1992). For that reason, transferrin enzyme among others is used in
preclinical animal studies to predict adverse liver effects in humans
(Amacher, 2002), and is seen in our zebrafish study as a marker for
hepatotoxicity of three tested compounds. The decreased expres-
sion of TF gene, resulting into disruption of normal iron metabo-
lism by affecting transferrin as a major protein involved in this
process (Hertz et al., 1996) might thus be one of the mechanisms
inducing liver damage after xenobiotic exposure.Chemical analysis
Zebrafish are often exposed by dissolving the compound in the
water, which enables easy and fast administration. This is an ad-
vantage of the model that allows for high-throughput screening.
As part of this study, the concentration of test compound in the
surrounding aqueous medium and within zebrafish larvae were
measured to assess uptake and to interpret appropriately the rel-
evance of any observed toxicity outcome. The protocol described
herein was successful at determining the amount of compound
present in tissue samples as small as five pooled larvae (120
hpf stage). All compounds were stable within the setup of these
experiments, except AMI for which precipitation was observed al-
ready after 24 h of exposure. A good agreement was observed
between the measured concentrations in the medium and the
nominal concentrations at the start of the experiments at 72
hpf and after 48 h exposure for all compounds. There was a wide
variation between the actual concentrations of compound in the
zebrafish larvae with a higher compound uptake of AMI, MET and
MYC being concentrated in the larvae up to 527, 920 and 180%
respectively of the concentration in the medium at the start in
function of the nominal concentration (for the highest concentra-
tion) after a 48h exposure period. Conversely, levels of COU and
SAC were <5% of the external concentration at 120 hpf, indicat-
ing a low compound uptake, whereas ACE exposure resulted in a
medium uptake (from 5 to 12%). Despite low relative uptake, it isJ. Appl. Toxicol. 2016 Copyright © 2016 Johnclear that the actual body concentration of the non-hepatotoxic
compound SAC is of the same order of magnitude as some hep-
atotoxic compounds (COU, AMI, MYC) while there is no pheno-
typic effect on liver (true negative). We also need to remark
that only parent compounds were measured in the larvae, and
levels of low to medium uptake might rather be the result of slow
to fast biotransformation and clearance of the parent com-
pounds, while metabolites could not be quantified in our analyt-
ical approach. There was an indication that compounds with low
log Kow (< 1.5) (or less lipophilic character) (Table 1) resulted in
low relative uptake. However, more compounds should be evalu-
ated and other physical–chemical properties should be included
to confirm this hypothesis.
A relationship between log Kow and compound uptake was
shown in a study using zebrafish-based assays for the assessment
of cardiac, visual and gut function (Berghmans et al., 2008), while
no correlation of compound uptake with log Kow values was
observed in another study using zebrafish as a screening tool for
developmental toxicity (Van den Bulck et al., 2011). On the other
hand, an association could be made between the amount of
compound uptake and the strength of gene expression responses,
e.g., high uptake of AMI was observed in larvae and exposure
resulted in a strong decreased expression of all hepatotoxicity
markers. No conclusion can be made for the other compounds
(ACE, COU), as they could have been metabolized, and no metab-
olites were measured in this study. Nonetheless, this could be the
subject of further studies. Measurement of the internal concentra-
tion of a parent compound or corresponding metabolites, consid-
ering uptake and clearance should be further investigated for their
value as a “threshold” for gene expression changes and hepato-
toxic effects.Conclusions
Our data support the use of zebrafish larvae as a predictive animal
model for assessing compound-induced hepatotoxicity. This con-
venient, predictive animalmodel can serve as an intermediate step
between cell-based evaluation and mammalian animal testing.
Mammalian evidence is available to confirm the hepatotoxic na-
ture of the five selected liver toxic compounds. Both ISH and
real-time RT-qPCR support the phenotypic observations on liver
toxicity in zebrafish. The results of the current study are part of
the ongoing development and validation of a test strategy using
a transgenic zebrafish line for a quick screening to prioritize un-
known compounds. Our goal is to develop a TF transgenic
zebrafish. With successful construction, the latter should first be
tested for its complementarity to the existing FABP10a transgenic
line for an extended panel of chemicals covering all the seven
mechanisms of human hepatotoxicity.Acknowledgments
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